U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"We live in a society exquisitely dependent on science and technology, in which hardly anyone knows anything about science and technology."

Carl Sagan

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Assignee: Biosyn Arzneimittel GmbH


Location: Fellbach, DE
No. of patents: 5

NumberTitleIssue Date
7282578Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin
A nucleic acid molecule or construct alone or with a promoter suitable for expression control is contemplated that codes for a KLH1 haemocyanin, a haemocyanin domain or a fragment thereof with the immunological properties of at least one domain of haemocyanin, and c...
10/16/2007
7273928Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin
A nucleic acid molecule or construct alone or with a promoter suitable for expression control is contemplated that codes for a HLH2 haemocyanin polypeptide and comprises at least one intron sequence, as well as haemocyanin fusion proteins. The construct further can ...
09/25/2007
7265217Recombinant mistletoe lectin
The present invention relates to processes for the production of mistletoe lectin polypeptides in homologous and heterologous host systems and mistletoe lectin peptides. Further, nucleic acid molecules are provided, which encode these mistletoe lectin polypeptides, ...
09/04/2007
6927207Recombinant mistletoe lectines
The present invention relates to isolated mistletoe lectin polypeptides and the pharmaceutical composition comprising the polypeptides thereof. Also, the present invention relates to processes for the production of mistletoe lectin polypeptides in homologous and het...
08/09/2005
6656509Combination of selenium-containing compounds with cytostatics
The present invention relates to the use of selenium and/or a derivative thereof in combination with one or more cytostatics. It is the object of the present invention to provide a possibility of enhancing the effect of antitumor drugs, and to provide said dru...
12/02/2003
 
Sign InRegister
Username  
Password   
forgot password?